LAVAL, QC, Jan. 25, 2018 /PRNewswire/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic") announced that it will host a Key Opinion Leader (KOL) meeting on the topic of novel treatments for idiopathic pulmonary fibrosis (IPF) on Wednesday, January 31 in New York City....